Catherine M. Szyman - 03 Sep 2024 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP, Critical Care
Signature: Linda J. Park, Attorney-in-Fact
Issuer symbol: EW
Transactions as of: 03 Sep 2024
Net transactions value: -$386,879
Form type: 4
Filing time: 03 Sep 2024, 19:10:37 UTC
Previous filing: 08 Jul 2024
Next filing: 14 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Award	$0	+10,910	+14%	$0.000000	86,817	03 Sep 2024	Direct	F1
transaction	EW	Common Stock	Tax liability	$386,879	-5,530	-6.4%	$69.96	81,287	03 Sep 2024	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units were granted on September 3, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are 100% vested and exercisable on the grant date.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.